PUVA and interferon α2b combined therapy for patients with mycosis fungoides at different stages of the disease: a seven‐year retrospective study in Russia
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.15212
Abstract: Mycosis fungoides (MF) is a clinical-pathologically heterogeneous group of Cutaneous T-Cell Lymphomas (CTCLs) primarily developing and affecting the skin. PUVA is the gold standard of treatment in early disease reaching up to 71.4% of complete… read more here.
Keywords: puva; puva interferon; mycosis fungoides; combined therapy ... See more keywords